Literature DB >> 23774117

Recovery from anesthesia after craniotomy for supratentorial tumors: comparison of propofol-remifentanil and sevoflurane-sufentanil (the PROMIFLUNIL trial).

Skander Necib1, Florence Tubach, Clarisse Peuch, Eric LeBihan, Emmanuel Samain, Jean Mantz, Souhayl Dahmani.   

Abstract

INTRODUCTION: Rapid recovery after supratentorial tumors (STT) removal is important. Short-acting anesthetics, such as propofol and remifentanil might favor this objective. The aim of this study was to compare the recovery of 2 Bispectral index (BIS)-guided anesthesia protocols combining sevoflurane-sufentanil (SS) or propofol-remifentanil (PR) administered during craniotomy for STT.
MATERIALS AND METHODS: After IRB approval and written consent, patients scheduled for surgical removal of STT were randomized to receive PR or SS. Anesthesia was adjusted to maintain BIS values between 45 and 55. The primary outcome was the time from discontinuation of anesthetics to extubation. Secondary endpoints were: time to respond to a simple order, and to achieve spontaneous ventilation, agitation score at emergence, postoperative Mini Mental State, postoperative Aldrete score, pain Visual Analogical Score, simplified sedation score, Glasgow Coma Scale, and surgical complications. Statistical analyses were performed using analysis of variance.
RESULTS: Thirty-five and 31 were included in the SS and PR groups, respectively. Times to extubation was not different between the 2 groups (11.8±6.9 vs. 13.0±8.1 min in PR and SS groups, respectively, P=0.577). Although times to achieve an Aldrete score to 10, a Glasgow Coma Scale to 15, and a MMS to 30 significantly were lower in SS group, no significant difference was found when analyzing time course of these 3 factors over the first postoperative day. All other secondary endpoints were not different between the 2 groups.
CONCLUSION: During craniotomy for STT, we could not demonstrate a reduction in the time to extubation when comparing a BIS-guided anesthesia associating PR to a BIS-guided anesthesia associating SS (Clinicatrials.gov identifier: NCT00389883).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23774117     DOI: 10.1097/ANA.0b013e31829cc2d6

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  5 in total

Review 1.  The Neurobiology of Anesthetic Emergence.

Authors:  Vijay Tarnal; Phillip E Vlisides; George A Mashour
Journal:  J Neurosurg Anesthesiol       Date:  2016-07       Impact factor: 3.956

2.  Comparison of the Sedative and Analgesic Effects of Dexmedetomidine-Remifentanil and Dexmedetomidine-Sufentanil for Liposuction: A Prospective Single-Blind Randomized Controlled Study.

Authors:  Ye Wang; Wenli Xu; Weipeng Xia; Lingxin Wei; Dong Yang; Xiaoming Deng; Fuxia Yan
Journal:  Aesthetic Plast Surg       Date:  2021-09-09       Impact factor: 2.326

3.  Sevoflurane versus PRopofol combined with Remifentanil anesthesia Impact on postoperative Neurologic function in supratentorial Gliomas (SPRING): protocol for a randomized controlled trial.

Authors:  Yan Xing; Nan Lin; Ruquan Han; John F Bebawy; Yuming Peng; Jiaxin Li; Xiaoyuan Liu; Yan Li; Jia Dong; Min Zeng; Manyu Zhang; Lanyi Nie
Journal:  BMC Anesthesiol       Date:  2020-05-19       Impact factor: 2.217

4.  Remifentanil-based propofol-supplemented vs. balanced sevoflurane-sufentanil anesthesia regimens on bispectral index recovery after cardiac surgery: a randomized controlled study.

Authors:  Tae-Yun Sung; Dong-Kyu Lee; Jiyon Bang; Jimin Choi; Saemi Shin; Tae-Yop Kim
Journal:  Anesth Pain Med (Seoul)       Date:  2020-10-30

5.  Meta-Analysis of Anesthetic Efficacy and Safety of Propofol in Craniotomy Patients.

Authors:  Qiang Zhou; Ya'nan Han; Jun Chen
Journal:  Contrast Media Mol Imaging       Date:  2022-08-18       Impact factor: 3.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.